Vygon GmbH & Co. KG
Prestataire R&D privé Contact |
||
|
Téléphone : +49 (0)241/9130-134
Mail :
Adresse :
Prager Ring 100
52070 Aachen
Allemagne
Web : www.vygon.de
|
||
|
Consultez cette fiche en intégralité ? |
||
|
Consultez cette fiche et près de 50 000 autres fiches de Centres de Recherche dans plus de 30 pays européens sur Expernova.com !
Inscrivez-vous ou contactez-nous pour une démonstration personnalisée.
Il s’agit de votre centre de Recherche ? Inscrivez-vous gratuitement et complétez vos informations. |
||
|
Description
(Extrait du site web) |
||
|
Vygon is a company that creates, produces and markets single-use sterile medical and surgical products.
Recently, Vygon has developed its activities in responding to each individual client, by offering ready-to-use packs and sets. This strategy helps to reduce workload and optimizes safety at a competitive rate. The Vygon Company strategy is clear, offer health professionals efficient and innovative single-use medical products adapted to their needs. With a high degree of quality and at a competitive price, we offer health-care professionals the best possible chances to treat and care for their patients in the most secured conditions. Innovation requires an understanding: our teams of marketing, R&D and sales representatives are working daily with our customers, listening to their needs, bringing creative and imaginative solutions to patient care. This high quality and responsive service compliments the proximity of production and research. That is why our plants are still located in Europe and in the United States of America. It?s our key to ensure constant high quality products. This policy and strategy, requires long term commitment and a real involvement of all Vygon partners and managers. Stability and commitment of our shareholders enable us to invest in the long term, opting for quality and innovation instead of short term profitability, giving our teams and clients the warranty of a long term vision that everybody needs. This willingness to act in the long term, some talk about Sustainable Development Strategy (SDS), allows Vygon to implement its leading vision of progress, integrating all stakeholders, in social, economic and environmental outcomes. This strategy has proven to be effective. Since fifty years now, Vygon attracts more and more partners around the world. We are now present in more than one hundred countries in five continents. Our regular growth and profitability, warranty of our independence and our ability to innovate, testifies the quality of our products and our customer satisfaction. |
||
|
|
||
|
|
||
|
Profil scientifique partiel |
||
|
|
||
|
Quelques documents de Vygon GmbH & Co. KG
|
||
Integration of Microcomponents in an Interventional Cardiac Catheter
IMICS Sujets :
Information Processing, Information Systems, Electronics, Microelectronics
Type de contrat :
No contract type
Participants :
Lilly Industries Ltd UNITED KINGDOM
Lilly Industries Ltd
Kingsclere Road RG21 2XA UNITED KINGDOM
HERIOT-WATT UNIVERSITY UNITED KINGDOM
HERIOT-WATT UNIVERSITY
RICCARTON EH14 4AS UNITED KINGDOM
VYGON ERZEUGNISSE FÜR MEDIZIN UND CHIRURGIE DEUTSCHLAND
VYGON ERZEUGNISSE FÜR MEDIZIN UND CHIRURGIE
Postfach 16 34 PRAGER RING 100 52070 DEUTSCHLAND
Papworth Hospital Trust UNITED KINGDOM
Papworth Hospital Trust
Papworth Everard CB3 8RE UNITED KINGDOM
Fraunhofer-Gesellschaft zur Förderungder Angewandten Forschung e.V. DEUTSCHLAND
Fraunhofer-Gesellschaft zur Förderungder Angewandten Forschung e.V.
Institut für Mikroelektronische Schaltungen und Systeme - IMS DUISBURG Finkenstrasse 47057 DEUTSCHLAND
Forschungszentrum Karlsruhe Technik und Umwelt GmbH DEUTSCHLAND
Forschungszentrum Karlsruhe Technik und Umwelt GmbH
Postfach 36 40 76021 DEUTSCHLAND
Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung eV (FhG) DEUTSCHLAND
Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung eV (FhG)
Institut für Biomedizinische Technik (IBMT) Ensheimer Straße 46 66386 DEUTSCHLAND
The IMICS project is concerned with the development of micro-mechanical and microelectronic components and subsystems, and their integration into an advanced cardiac catheter system for plaque removal. More specifically, the project will aim to develop a system which integrates the sensing and signal processing (diagnostic) function with the microactuating (therapeutic) function in a catheter head of overall external diameter between 2 and 4 mm.
Hide general information
To achieve this objective, efforts will be focused on the following areas: - microactuating and therapeutic subsystems development, including both electrostatically and/or fluid-driven versions. 3D simulation studies will form the basis for the design of these components and fabrication will rely on advanced LIGA procedures. - evolution of a micro-miniature ultrasonic sensing system capable of determining the location and quality of intravascular plaque deposits, and of monitoring the progress of therapy. Advanced ultrasonic array technology in conjunction with CMOS based microprocessor chip developments will be required to realise this task. - development of a positioning system capable of fixing the catheter in position within the artery wall whilst therapeutic action being performed. - integration of electronic and micro-mechanical subsystems within a 2 to 4 mm catheter head. It will be based on a series of expandable units, constructed using biocompatible balloon technology, which, by dilation, will be brought into contact with the artery wall by means of an array of active micro-valves. Successful integration will hinge on the development of novel techniques for fabricating, handling and assembling submillimetre and micron scale sub-assemblies and components, while assessment and evaluation of the biocompatibility and reliability of catheter materials and components will form a significant element in the programme.
Source :
cordis
|
||
